Atıf İçin Kopyala
Bulbul E. O., Karantas I. D., Okur M. E., Siafaka P., Okur N. U.
CURRENT PHARMACEUTICAL DESIGN, cilt.26, sa.31, ss.3871-3883, 2020 (SCI-Expanded)
-
Yayın Türü:
Makale / Derleme
-
Cilt numarası:
26
Sayı:
31
-
Basım Tarihi:
2020
-
Doi Numarası:
10.2174/1381612826666200523173102
-
Dergi Adı:
CURRENT PHARMACEUTICAL DESIGN
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, Agricultural & Environmental Science Database, BIOSIS, Biotechnology Research Abstracts, CAB Abstracts, Chemical Abstracts Core, EMBASE, MEDLINE, Veterinary Science Database
-
Sayfa Sayıları:
ss.3871-3883
-
İstanbul Üniversitesi Adresli:
Hayır
Özet
Background: Schizophrenia belongs to mental illnesses affecting 1% of the worldwide population. Its therapy is still unmet; thus, researchers aimed to develop new pharmacological molecules which can improve its management.